Home › Funds › Citigroup Inc › RYTM
Citigroup Inc position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)58.35K sh
Reported value held$6.48M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 59.73K | $780.00K | New |
| Q4 2021 | 96.02K | $958.00K | Add |
| Q1 2022 | 4.53K | $52.00K | Reduce |
| Q2 2022 | 2.27K | $9.00K | Reduce |
| Q3 2022 | 512.19K | $12.55M | Add |
| Q4 2022 | 365.56K | $10.65M | Reduce |
| Q1 2023 | 439.95K | $7.85M | Add |
| Q2 2023 | 88.06K | $1.45M | Reduce |
| Q3 2023 | 69.14K | $1.59M | Reduce |
| Q4 2023 | 54.30K | $2.50M | Reduce |
| Q1 2024 | 190.52K | $8.26M | Add |
| Q2 2024 | 19.99K | $820.87K | Reduce |
| Q3 2024 | 41.20K | $2.16M | Add |
| Q4 2024 | 69.78K | $3.91M | Add |
| Q1 2025 | 86.21K | $4.57M | Add |
| Q2 2025 | 34.32K | $2.17M | Reduce |
| Q3 2025 | 13.08K | $1.32M | Reduce |
| Q4 2025 | 12.72K | $1.36M | Reduce |
| Q1 2026 | 12.34K | $1.07M | Reduce |
| Q2 2026 | 58.35K | $6.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RYTM
- BlackRock Inc 6.16M sh · $683.60M · Q2 2026
- Vanguard Group 6.21M sh · $664.82M · Q4 2025
- JPMorgan Chase & Co 2.65M sh · $292.18M · Q2 2026
- Goldman Sachs Group 2.13M sh · $236.11M · Q2 2026
- Geode Capital Management 1.53M sh · $170.32M · Q2 2026
- Capital Research Global Investors 1.53M sh · $170.13M · Q2 2026
- Morgan Stanley 1.11M sh · $123.49M · Q2 2026
- Fidelity Management & Research (FMR) 1.03M sh · $113.90M · Q2 2026
- Janus Henderson Group 918.15K sh · $79.89M · Q1 2026
- Norges Bank Investment Management 685.84K sh · $76.15M · Q2 2026
- Franklin Resources 577.03K sh · $64.07M · Q2 2026
- Charles Schwab Investment Management 552.74K sh · $61.37M · Q2 2026